|
|
Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows:
- vascular devices (38.4%): endoprosthetic systems, dilation catheters, arterial closures, etc.;
- diagnostic systems and instruments (24.2%);
- nutrition products (23.2%): pediatric nutrition products, nutritional supplements, and dietetic products;
- medicine (14.1%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc.;
- other (0.2%).
Net sales are distributed geographically as follows: the United States (35.7%), China (7.4%), Germany (5.5%), Japan (4.5%), India (4.4%), Switzerland (3.3%), the Netherlands (3.1%) and other (36.1%).
Number of employees : 107 000 people.
|
|
|
| 2019 | | USD (in Million) | % | | Medical Devices | 12,239 | 38.4% | | Diagnostics | 7,713 | 24.2% | | Nutritionals | 7,409 | 23.2% | | Established Pharmaceuticals | 4,486 | 14.1% | | Other | 57.00 | 0.2% |
|
|
|
| 2018 | 2019 | Delta | | USD (in Million) | % | USD (in Million) | % | | All Other Countries | 11,215 | 36.7% | 11,534 | 36.2% | +2.84% | | United States | 10,839 | 35.4% | 11,398 | 35.7% | +5.16% | | China | 2,311 | 7.6% | 2,346 | 7.4% | +1.51% | | Germany | 1,619 | 5.3% | 1,751 | 5.5% | +8.15% | | Japan | 1,326 | 4.3% | 1,435 | 4.5% | +8.22% | | India | 1,333 | 4.4% | 1,397 | 4.4% | +4.8% | | Switzerland | 1,005 | 3.3% | 1,068 | 3.3% | +6.27% | | The Netherlands | 930.00 | 3% | 975.00 | 3.1% | +4.84% |
|
|
|
| Vote  | Quantity | Free-Float | Company-owned shares | Total Float |
| Stock A |
1 |
1,979,594,379 |
1,758,285,187 |
88.8% |
209,064,380 |
10.6% |
88.8% |
|
|
|
| Name | Equities | % | | The Vanguard Group, Inc. | 141,677,968 |
8.00% | | Capital Research & Management Co. | 100,782,100 |
5.69% | | Capital Research & Management Co. (Global Investors) | 87,417,734 |
4.94% | | SSgA Funds Management, Inc. | 74,556,021 |
4.21% | | Capital Research & Management Co. (International Investors) | 56,714,070 |
3.20% | | BlackRock Fund Advisors | 42,612,898 |
2.41% | | Wellington Management Co. LLP | 35,926,910 |
2.03% | | Northern Trust Investments, Inc.(Investment Management) | 27,034,512 |
1.53% | | Geode Capital Management LLC | 25,238,694 |
1.43% | | Massachusetts Financial Services Co. | 24,455,855 |
1.38% |
|
|
|
| Name | Equities | % | Valuation |
| Abbott India Limited (500488) | 15,934,048 | 75.0% | 3,545,170,164 USD | | Abbott Laboratories (Pakistan) Limited (ABOT) | 76,259,451 | 77.9% | 353,540,340 USD | | Allergy Therapeutics plc (AGY) | 240,584,571 | 37.8% | 55,324,828 USD | | Domesco Medical Import - Export Joint-Stock Corporation (DMC) | 17,949,800 | 51.7% | 40,972,752 USD | | Kilroy Realty Corporation (KRC) | 165 | 0.0001% | 9,656 USD |
|
|
|
|
- - Main Market - S&P 100 / S&P 500, Stoxx Americas 100, Stoxx Global 200, Stoxx NorthAmerica 50, Stoxx USA 50 |
|
|
|
|
| - Bloomberg Code : |
ABT:US |
| - Reuters Code : |
ABT.N |
| - Datastream Code : |
|
|
| Company contact information |
|
Abbott Laboratories 100 Road Abbott Park IL 60064-6400 Palatine, Illinois Phone : +1 (224) 667 6400 Fax : Internet : http://www.abbott.com |
|
|
Sector Medical Equipment, Supplies & Distribution - NEC
Connections : Abbott Laboratories |
United Kingdom
Canada
France
Deutschland
Schweiz (DE)
Report
